1887
Volume 2024, Issue 4
  • ISSN: 1999-7086
  • EISSN: 1999-7094

Abstract

The aim of this study was to determine the association of HbA1c with coronary artery disease (CAD) in non-diabetic patients undergoing coronary artery angiography.

This cross-sectional study was conducted on 265 individuals referred to an educational heart hospital affiliated with Urmia University of Medical Sciences, north of Iran. Participants were selected through a convenient sampling method. Patients underwent angiography, and CAD disease severity for them was computed using a GSS score. The association of HbA1c and other variables on CAD disease severity was investigated.

A total of 265 non-diabetic diabetic patients with a mean age of 59.36 years were investigated. The mean body mass index was 26.42 kg/m2 and the mean left ventricular ejection fraction (LVEF) was 48.62%. The mean score of the Geriatric Scoring System in patients was 31.28. As the GSS score increased, HbA1c was significantly increased as well. HbA1c had an appropriate value in the diagnosis of severe CAD, and the best cutoff point for this assessment was 6.15%. In addition, HbA1c had an appropriate value in the diagnosis of mild CAD, but cigarette use and hypertension had no significant effect on this association.

HbA1c with cutoff points mentioned was an appropriate factor to determine the severity of CAD in non-diabetic patients; therefore, it is recommended to use that to determine disease severity, and in patients with high levels of HbA1c, close follow-up and treatment need to be done to decrease the complications and mortality.

Loading

Article metrics loading...

/content/journals/10.5339/jemtac.2024.19
2024-08-20
2024-09-06
Loading full text...

Full text loading...

/deliver/fulltext/jemtac/2024/4/jemtac.2024.19.html?itemId=/content/journals/10.5339/jemtac.2024.19&mimeType=html&fmt=ahah

References

  1. Felisbino-Mendes MS, Cousin E, Malta DC, Machado IE, Ribeiro AL, Duncan BB, et al. The burden of non-communicable diseases attributable to high BMI in Brazil, 1990–2017: Findings from the Global Burden of Disease Study. Population Health Metrics. 2020; 18:(1):18. https://doi.org/10.1186/s12963-020-00219-y
    [Google Scholar]
  2. Pezel T, Hovasse T, Kinnel M, Unterseeh T, Champagne S, Toupin S, et al. Prognostic value of stress cardiovascular magnetic resonance in asymptomatic patients with known coronary artery disease. J Cardiovasc Magn Reson. 2021; 23:(1):1. https://doi.org/10.1186/s12968-021-00721-8
    [Google Scholar]
  3. Amini M, Zayeri F, Salehi M. Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: Results from global burden of disease study 2017. BMC Public Health. 2021; 21:(1):401. https://doi.org/10.1186/s12889-021-10429-0
    [Google Scholar]
  4. Mehta LS, Warnes CA, Bradley E, Burton T, Economy K, Mehran R, et al. Cardiovascular considerations in caring for pregnant patients: A scientific statement from the American Heart Association. Circulation. 2020; 141:(23):e884–903. https://doi.org/10.1161/CIR.0000000000000772
    [Google Scholar]
  5. De Hert M, Detraux J, Vancampfort D. The intriguing relationship between coronary heart disease and mental disorders. Dialogues Clin Neurosci. 2018; 20:(1):31–40. https://doi.org/10.31887/DCNS.2018.20.1/mdehert
    [Google Scholar]
  6. Nasitowska-Barud A, Zapolski T, Barud M, Wysokinski A. Overt and covert anxiety as a toxic factor in ischemic heart disease in women: The link between psychological factors and heart disease. Med Sci Monit. 2017; 23:751–8. https://doi.org/10.12659/msm.902544
    [Google Scholar]
  7. Bugiardini R, Yoon J, Kedev S, Stankovic G, Vasiljevic Z, Miličić, et al. Prior beta-blocker therapy for hypertension and sex-based differences in heart failure among patients with incident coronary heart disease. Hypertension. 2020; 76:(3):819–26. https://doi.org/10.1161/HYPERTENSIONAHA.120.15323
    [Google Scholar]
  8. John RM, Sinha P, Munish VG, Tullu FT. Economic costs of diseases and deaths attributable to tobacco use in India, 2017–2018. Nicotine Tobacco Res. 2021; 23:(2):294–301. https://doi.org/10.1093/ntr/ntaa154
    [Google Scholar]
  9. Pastori D, Biccire FG, Lip GY, Menichelli D, Pignatelli P, Barilla F, et al. Relation of atrial fibrillation to angiographic characteristics and coronary artery disease severity in patients undergoing percutaneous coronary intervention. Am J Cardiol. 2021; 141:1–6. https://doi.org/10.1016/j.amjcard.2020.11.006
    [Google Scholar]
  10. Nowbar AN, Rajkumar C, Al-Lamee RK, Francis DP. Controversies in revascularisation for stable coronary artery disease. Clin Med. 2021; 21:(2):114. https://doi.org/10.7861/clinmed.2020-0922
    [Google Scholar]
  11. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): Effects on mortality and morbidity. Eur Heart J. 2005; 26:650–61. https://doi.org/10.1093/eurheartj/ehi199
    [Google Scholar]
  12. Song F, Zhou Y, Zhang K, Liang YF, He X, Li L. The role of the plasma glycosylated hemoglobin A1c/Apolipoprotein Al ratio in predicting cardiovascular outcomes in acute coronary syndrome. Nutr Metab Cardiovasc Dis. 2021;8; 31:(2):570–8https://doi.org/10.1016/j.numecd.2020.10.008
    [Google Scholar]
  13. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 2010; 362:800–11. https://doi.org/10.1056/NEJMoa0908359
    [Google Scholar]
  14. Au Yeung SL, Luo S, Schooling CM. The impact of glycated hemoglobin (HbA1c) on cardiovascular disease risk: A Mendelian randomization study using UK Biobank. Diabetes Care. 2018; 41:(9):1991–7https://doi.org/10.2337/dc18-0289
    [Google Scholar]
  15. Nardin M, Verdoia M, Barbieri L, De Luca G, Novara Atherosclerosis Study Group (NAS). Impact of metabolic syndrome on mean platelet volume and its relationship with coronary artery disease. Platelets. 2019; 30:(5):615–23https://doi.org/10.1080/09537104.2018.1499885
    [Google Scholar]
  16. Lang IM, Badr-Eslam R, Greenlaw N, Young R, Steg PG. Management and clinical outcome of stable coronary artery disease in Austria: Results from 5 years of the CLARIFY registry. Wien Klin Wochenschr. 2017Dec; 129:(23–24):879–92. https://doi.org/10.1007/s00508-017-1248-1
    [Google Scholar]
  17. Dutta B, Neginhal M, Iqbal F. Glycated hemoglobin (HbA1c) correlation with severity of coronary artery disease in non-diabetic patients: A hospital based study from North-Eastern India. J Clin Diagn Res. 2016Sep; 10:(9):OC20–3. https://doi.org/10.7860/JCDR/2016/22378.8525
    [Google Scholar]
  18. Ashraf H, Boroumand MA, Amirzadegan A, Talesh SA, Davoodi G. Hemoglobin A1C in non-diabetic patients: An independent predictor of coronary artery disease and its severity. Diabetes Res Clin Pract. 2013; 102:(3):225–32. https://doi.org/10.1016/j.diabres.2013.10.011
    [Google Scholar]
  19. Chang Y, Yun KE, Jung H-S, Kim C-W, Kwon M-J, Sung E, et al. A1C and coronary artery calcification in nondiabetic men and women. Arterioscler Thromb Vasc Biol. 2013; 33:(8):2026–31https://doi.org/10.1161/ATVBAHA.113.301587
    [Google Scholar]
  20. Naito R, Miyauchi K, Ogita M, Kasai T, Kawaguchi Y, Tsuboi S, et al. Impact of admission glycemia and glycosylated hemoglobin A1c on long-term clinical outcomes of non-diabetic patients with acute coronary syndrome. J Cardiol. 2013Feb; 63:(2):106-11. https://doi.org/10.1016/j.jjcc.2013.07.009
    [Google Scholar]
  21. Daida H, Takayama T, Hiro T, Yamagishi M, Hirayama A, Saito S, et al. High HbA1c levels correlate with reduced plaque regression during statin treatment in patients with stable coronary artery disease: Results of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS). Cardiovasc Diabetol. 2012; 11:87. https://doi.org/10.1186/1475-2840-11-87
    [Google Scholar]
  22. Oh HG, Rhee E-J, Kim T-W, Lee KB, Park J-H, Yang K-I, et al. Higher glycated hemoglobin level is associated with increased risk for ischemic stroke in non-diabetic Korean male adults. Diab Metab J. 2011; 35:(5):551–7. https://doi.org/10.4093/dmj.2011.35.5.551
    [Google Scholar]
  23. Ikeda N, Iijima R, Hara H, Moroi M, Nakamura M, Sugi K. Glycated hemoglobin is associated with the complexity of coronary artery disease, even in non-diabetic adults. J Atheroscler Thromb. 2011; 19:(12):1066–72. https://doi.org/10.5551/jat.13722
    [Google Scholar]
  24. Farrag A, Ammar W, Hady AE, Samhoon NE. Haemoglobin A1c as a marker predicting extent and severity of coronary artery disease in non-diabetic patients. Acta Cardiol. 2016; 71:(5):581–5https://doi.org/10.2143/AC.71.5.3167502
    [Google Scholar]
  25. Saleem T, Mohammad KH, Abdel-Fattah MM, Abbasi AH. Association of glycosylated haemoglobin level and diabetes mellitus duration with the severity of coronary artery disease. Diab Vasc Dis Res. 2008; 5:(3):184–9. https://doi.org/10.3132/dvdr.2008.030
    [Google Scholar]
  26. Ahmad S, Xue Z, Silverman A, Lindsay J. Complexity of the relation between hemoglobin A1C, diabetes mellitus, and progression of coronary narrowing in postmenopausal women. Am J Cardiol. 2013;15; 111:(6):793–99. https://doi.org/10.1016/j.amjcard.2012.11.057
    [Google Scholar]
/content/journals/10.5339/jemtac.2024.19
Loading
/content/journals/10.5339/jemtac.2024.19
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): angiographydiabetes mellitusglycated hemoglobinhypertension and stroke volume
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error